BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5607560)

  • 1. [Renal function in chronic uremic patients treated with periodic depuration].
    Casciani C
    Minerva Nefrol; 1967; 14(4):189-92. PubMed ID: 5607560
    [No Abstract]   [Full Text] [Related]  

  • 2. [Some aspects of gastric secretion in chronic uremic patients in periodic hemodialysis].
    Guarini G; Bruscagli GF; Cordova C; Santucci A; Cerulli N; Bruno S
    Minerva Nefrol; 1970; 17(6):181-3. PubMed ID: 5516051
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of dietetic integration with essential amino acids in uremic patients treated with long-term hemodialysis].
    Costa A; Rovati C; Degetto P; Midiri R; Valli A; Lo Dico C; Arw K; Frizzi R; Niccolini A; Andreotti C; Comotti C
    Minerva Dietol Gastroenterol; 1981; 27(1):141-5. PubMed ID: 7254597
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gastric secretion in chonic uremic patients undergoing periodical hemodialysis].
    Butti A; Nanni G; Pigliucci GM; Ronzoni G; Cascini V; Maria G
    Chir Patol Sper; 1974 Oct; 22(5):277-301. PubMed ID: 4465072
    [No Abstract]   [Full Text] [Related]  

  • 5. [Partial recovery of kidney function in patients with chronic uremia during hemodialysis treatment].
    Ermolenko VM; Del'machinskiĭ BV; Rozhdestvenskaia TM; Tareeva IE
    Ter Arkh; 1985; 57(6):145-7. PubMed ID: 4071405
    [No Abstract]   [Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of cellulose diacetate dialysis membranes on lipids and lipoproteins in uremic patients].
    Jakić M; Rupcić V; Stipanić S; Samardzija G; Bilandzija M; Zibar L; Mihaljević D; Milas J
    Lijec Vjesn; 1997 Feb; 119(2):56-9. PubMed ID: 9297037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The intervals of ventricular systole in uremic patients treated with periodic hemodialysis. Polygraphic study].
    Sodi A; Rizzo M; Durval A; Biagioni-Sodi A; Turini D; Pampanini A
    Mal Cardiovasc; 1968; 9(3):441-70. PubMed ID: 5705928
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aspects of carbohydrate metabolism in chronic uremic patients treated with periodic hemodialysis].
    Redaelli B; Salvadeo A; Ponticelli C; Imbasciati E; Graziani G
    Minerva Nefrol; 1967; 14(4):158-62. PubMed ID: 5607555
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of lipochromes (urochromes) in uremic patients and normal controls I: the elimination of plasma lipochromes by hemodialysis.
    Tsaltas TT
    Trans Am Soc Artif Intern Organs; 1969; 15():321-7. PubMed ID: 4893031
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modification of uremic thrombocytopathy by hemodialysis].
    Frick U; Frick G; Vitu J; Wiedenhöft I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):309-13. PubMed ID: 6194064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dopamine 17-beta-hydroxylase in chronic uremic patients under periodic hemodialytic treatment].
    Cagossi M; Pigliucci GM; Ruvolo MR; Porcelli G
    Chir Patol Sper; 1979 Dec; 27(6):579-89. PubMed ID: 400642
    [No Abstract]   [Full Text] [Related]  

  • 13. [The visual apparatus in the chronic uremic patient during periodic hemodialytic treatment. II. Changes in ocular refraction during hemodialysis].
    Ambrosio A; Sorice PS; Tufano L; Tonna G; Esposito E
    Rass Int Clin Ter; 1971 Jul; 51(13):789-95. PubMed ID: 5568452
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of the blood platelets in chronic dialyzed patients before and after hemodialysis. Comparison with a group of patients with grave chronic uremia treated with occasional dialysis].
    Praga C; Brancaccio D; Pogliani E; Della Grazia M
    Minerva Nefrol; 1968; 15(5):322-6. PubMed ID: 5743459
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in serum lipoproteins in kidney diseases].
    Mordasini R; Riesen W
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1335-40. PubMed ID: 6755693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renal substitutive programs on amino acid patterns in chronic uremia.
    Scolari MP; Stefoni S; Mosconi G; Colì L; Feliciangeli G; Baldrati L; Buscaroli A; Prandini R; Bonomini V
    Kidney Int Suppl; 1983 Dec; 16():S77-80. PubMed ID: 6376922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric acid production in chronic uremia and following renal transplantation.
    Gingell JC; Burns GP; Chisholm GD
    Br J Surg; 1968 Nov; 55(11):864. PubMed ID: 4879795
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in glomerular permeability and tubular reabsorption of serum proteins after hemodialysis].
    Migone L; Maiorca R; Scarpioni L; Cambi V; Carrara GC; Dall'Aglio P
    Minerva Nefrol; 1969; 16(1):15-22. PubMed ID: 5768262
    [No Abstract]   [Full Text] [Related]  

  • 19. [The influence of twice-weekly hemodialytic treatment on the hypertensive syndrome in chronic uremic patients].
    Cioni L; Biagini M; Gloria E; Pentimone F
    Minerva Nefrol; 1966; 13(4):112-5. PubMed ID: 5995530
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of hypersiderosis. The long-term iron supplement in uremic patients treated with periodic dialysis].
    Lusvarghi E; Lamperi S
    Minerva Nefrol; 1982; 29(2):71-83. PubMed ID: 7133542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.